U.S. FDA approves BioDelivery's drug for opioid dependence

class="mandelbrot_refrag">BioDelivery Sciences International Inc said it had received U.S. regulatory approval for its drug, Bunavail, to treat opioid dependence.

_0">

The company's shares rose 8.5 percent to $10.85 in extended trading on Friday.

BioDelivery said it expects to launch the drug late in the third quarter ending Sept. 30.

 
 
 

Opioid dependence affects more than 2 million people in the United States.

(Reporting by Shailesh Kuber in Bangalore; Editing by Maju Samuel)

Popular posts from this blog

Model Stella Tennant dies 'suddenly' aged 50 as her family pay tribute to 'wonderful woman and an inspiration to us all'

ALL ABOUT CAR INSURANCE:

Best Online MBBS Colleges in the USA